Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

CTXRCTXR
3 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in CITIUS PHARMACEUTICALS INC

CITADEL ADVISORS LLC holds 124,910 shares of CTXR (CITIUS PHARMACEUTICALS INC), worth $75,508 as of 2026-Q2. This is a new position.

Current Value

$75,508

Current Shares

124,910

Total Value Change

+$75,504

Total Shares Change

+124,909

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
124,910
-
$75,5080.0%$0.61
33
2025-Q1
Exited
0
-100.0%
$00.0%$1.55
0
2024-Q4
New
1
-
$40.0%$3.91
17

Other major holders of CTXR: VANGUARD GROUP INC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used